{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:57:21Z","timestamp":1793066241679,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.msard.2024.105433","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T22:33:47Z","timestamp":1704494027000},"page":"105433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0700-3517","authenticated-orcid":false,"given":"Jo\u00e3o Vitor","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Solti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Lu\u00edsa","family":"Ap\u00f3stolos-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarso","family":"Adoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagoberto","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105433_bib0023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.msard.2024.105433_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000597","article-title":"Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105433_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101957","article-title":"High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: A randomised clinical trial","volume":"59","author":"Cassard","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.msard.2024.105433_bib0029","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105433_bib0003","doi-asserted-by":"crossref","first-page":"e1950","DOI":"10.1212\/WNL.0000000000009371","article-title":"Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT","volume":"94","author":"Cortese","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105433_bib0010","article-title":"High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial","volume":"6","author":"D\u00f6rr","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2024.105433_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105564","article-title":"The effects of vitamin D supplementation on Expanded Disability Status Scale in people with multiple sclerosis: a critical, systematic review and meta-analysis of randomized controlled trials","volume":"187","author":"Doosti-Irani","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105433_bib0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2024.105433_bib0028","doi-asserted-by":"crossref","first-page":"fcac171","DOI":"10.1093\/braincomms\/fcac171","article-title":"Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications","volume":"4","author":"Galoppin","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.msard.2024.105433_bib0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105433_bib0015","first-page":"42","article-title":"Effect of vitamin D supplements on relapse rate and expanded disability status scale (EDSS) in multiple sclerosis (MS): a systematic review and meta-analysis","volume":"12","author":"Ghajarzadeh","year":"2021","journal-title":"Int. J. Prevent. Med."},{"key":"10.1016\/j.msard.2024.105433_bib0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2377-13-60","article-title":"Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties","volume":"13","author":"Golan","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2024.105433_bib0021","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archneurol.2008.505","article-title":"Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis","volume":"66","author":"Gorman","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.105433_bib0030","series-title":"Doing Meta-Analysis with R: A Hands-On Guide","author":"Harrer","year":"2021"},{"key":"10.1016\/j.msard.2024.105433_bib0020","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.msard.2024.105433_bib0009","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105433_bib0018","series-title":"Dietary Reference Intakes for Calcium and Vitamin D","article-title":"Committee to review dietary reference intakes for vitamin D and calcium","year":"2011"},{"key":"10.1016\/j.msard.2024.105433_bib0012","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/1352458513489756","article-title":"The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis","volume":"19","author":"James","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105433_bib0026","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2024.105433_bib0016","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: a meta-analysis","volume":"265","author":"McLaughlin","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105433_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001866","article-title":"Vitamin D and risk of multiple sclerosis: a mendelian randomization study","volume":"12","author":"Mokry","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.msard.2024.105433_bib0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.msard.2024.105433_bib0002","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2024.105433_bib0017","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2024.105433_bib0019","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2017.4392","article-title":"Trends in use of high-dose vitamin D supplements exceeding 1000 or 4000 international units daily, 1999\u20132014","volume":"317","author":"Rooney","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2024.105433_bib0024","series-title":"RStudio: Integrated Development for R. RStudio","year":"2020"},{"key":"10.1016\/j.msard.2024.105433_bib0006","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105433_bib0008","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000002316","article-title":"Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis","volume":"86","author":"Sotirchos","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105433_bib0022","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2024.105433_bib0013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The efficacy of vitamin D in multiple sclerosis: a meta-analysis","volume":"23","author":"Zheng","year":"2018","journal-title":"Multipl. Scleros. Relate. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:41Z","timestamp":1761901661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"alternative-id":["S2211034824000129"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105433","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105433"}}